Moderna (MRNA.O) said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate to wait for efficacy data from a late-stage trial of its influenza shot, which is due later this year.
The delay was largely expected after Moderna said earlier this month that it does not anticipate approval of the shot until 2026 due to the need for more data on the flu vaccine.
Moderna pulls application for COVID-flu combination shot https://t.co/LcZC4O1tc0 https://t.co/LcZC4O1tc0
— Reuters (@Reuters) May 21, 2025
Moderna has withdrawn its application for the combined COVID/flu shot … on the same day that a report drops that the US knew about the myocarditis risk their shots posed ππ₯
— The Conservative Alternative (@OldeWorldOrder) May 21, 2025
The plot thickens…. https://t.co/3xw9mSRVOs pic.twitter.com/xB7Ea5aQG8
